CHARACTERIZATION AND LOCALIZATION OF [I-125] RTI-55-LABELED COCAINE BINDING-SITES IN FETAL AND ADULT-RAT BRAIN

Citation
Lp. Shearman et al., CHARACTERIZATION AND LOCALIZATION OF [I-125] RTI-55-LABELED COCAINE BINDING-SITES IN FETAL AND ADULT-RAT BRAIN, The Journal of pharmacology and experimental therapeutics, 277(3), 1996, pp. 1770-1783
Citations number
79
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
00223565
Volume
277
Issue
3
Year of publication
1996
Pages
1770 - 1783
Database
ISI
SICI code
0022-3565(1996)277:3<1770:CALO[R>2.0.ZU;2-4
Abstract
The present studies examined the characteristics of fetal (gestational day 20) and adult rat brain cocaine recognition sites labeled with th e potent cocaine congener [I-125]RTI-55 [3 beta-(4-iodophenyl)-tropane -2 beta-carboxylic acid methyl ester]. Saturation analyses of [I-125]R TI-55 binding to membrane fractions from both fetal and adult whole-br ain yielded curvilinear Scatchard plots that were resolved by nonlinea r curve-fitting into high- and low-affinity components. Mean K-d value s were 0.13 nM and 12 nM for fetal brain high- and low-affinity sites, respectively, compared to 0.26 and 18 nM for adult brain. The K-d for high-affinity binding was significantly different between the groups, suggesting a possible developmental change in the properties of [I-12 5]RTI-55 binding sites. Drug displacement studies with various monoami ne uptake inhibitors indicated that at a 10 pM concentration of [I-125 ]RTI-55, almost all binding to fetal brain membranes could be accounte d for by interaction with the serotonin (5-HT) and (to a lesser extent ) dopamine (DA) transporters. This conclusion was supported by autorad iographic studies of both adult and fetal brain, demonstrating a predo minance of [I-125]RTI-55 binding in areas with high densities of 5-HT and/or DA uptake sites. The present results are in accordance with our previous demonstration of [H-3]cocaine binding si les in fetal brain (Meyer et al., 1993) and further suggest that [I-125]RTI-55 should be a useful ligand for assessing the effects of prenatal cocaine exposure on the subsequent development of cocaine recognition sites on the DA and 5-HT transporters.